Nasdaq to Delist BNB Treasury Firm Windtree Therapeutics, Stock Crashes 76%

image

Windtree Therapeutics will be delisted from the Nasdaq Capital Market after failing to meet listing requirements, a decision that triggered a massive sell-off in its stock.